AMS (American Shared Hospital Services) Stock Analysis - News

American Shared Hospital Services (AMS) is a publicly traded Healthcare sector company. As of May 21, 2026, AMS trades at $1.33 with a market cap of $9.28M and a P/E ratio of -6.09. AMS moved -0.37% today. Year to date, AMS is -38.99%; over the trailing twelve months it is -44.58%. Its 52-week range spans $1.25 to $3.59. Rallies surfaces AMS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What changed in AMS news today?

American Shared Hospital Services Q1 Revenue Rises 15.9%, Adjusted EBITDA Up 18.4%: American Shared Hospital Services posted first-quarter 2026 revenue of $7.1 million, a 15.9% increase driven by a 30.2% rise in direct patient services to $4.1 million while leasing revenue held at $3.0 million. Gross margin grew 36.7% to $1.3 million (18.2%), operating loss narrowed to $0.9 million, adjusted EBITDA climbed 18.4% to $1.1 million, and Gamma Knife and PBRT volumes rose 10.1% and 20.7%.

AMS Key Metrics

Key financial metrics for AMS
MetricValue
Price$1.33
Market Cap$9.28M
P/E Ratio-6.09
EPS$-0.22
Dividend Yield0.05%
52-Week High$3.59
52-Week Low$1.25
Volume74
Avg Volume0
Revenue (TTM)$29.05M
Net Income$-2.78M
Gross Margin18.62%

Latest AMS News

AMS Analyst Consensus

AMS analyst coverage data. Average price target: $0.00.

Common questions about AMS

What changed in AMS news today?
American Shared Hospital Services Q1 Revenue Rises 15.9%, Adjusted EBITDA Up 18.4%: American Shared Hospital Services posted first-quarter 2026 revenue of $7.1 million, a 15.9% increase driven by a 30.2% rise in direct patient services to $4.1 million while leasing revenue held at $3.0 million. Gross margin grew 36.7% to $1.3 million (18.2%), operating loss narrowed to $0.9 million, adjusted EBITDA climbed 18.4% to $1.1 million, and Gamma Knife and PBRT volumes rose 10.1% and 20.7%.
Does Rallies summarize AMS news?
Yes. Rallies summarizes AMS news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is AMS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for AMS. It does not provide personalized investment advice.
AMS

AMS